开云app官网登录入口网页版-官方正版

#TCT#

61篇内容 | 2083人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1394670, encodeId=52b713946e026, content=<a href='/topic/show?id=d85b1e2171d' target=_blank style='color:#2F92EE;'>#TCT#</a>, objectTitle=TCT 2022：新型Bashir导管或将成为治疗肺栓塞的利器, objectType=article, longId=739786, objectId=e3bae39786a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3bae39786a2, replyNumber=0, likeNumber=79, createdTime=2022-09-19, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3bae39786a2, moduleTitle=TCT 2022：新型Bashir导管或将成为治疗肺栓塞的利器, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e3bae39786a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1394669, encodeId=aad51394669ad, content=<a href='/topic/show?id=d85b1e2171d' target=_blank style='color:#2F92EE;'>#TCT#</a>, objectTitle=TCT 2022：患者-人工瓣膜不匹配（PPM）与TAVR术后死亡率增加有关, objectType=article, longId=739778, objectId=d509e3977819, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d509e3977819, replyNumber=0, likeNumber=87, createdTime=2022-09-19, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d509e3977819, moduleTitle=TCT 2022：患者-人工瓣膜不匹配（PPM）与TAVR术后死亡率增加有关, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d509e3977819)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1394668, encodeId=b14c139466806, content=<a href='/topic/show?id=d85b1e2171d' target=_blank style='color:#2F92EE;'>#TCT#</a>, objectTitle=TCT 2022：TAVR 和 SAVR 治疗趋势，近50%重度主动脉瓣狭窄患者进行TAVR治疗, objectType=article, longId=739756, objectId=389fe3975635, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=389fe3975635, replyNumber=0, likeNumber=83, createdTime=2022-09-19, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=389fe3975635, moduleTitle=TCT 2022：TAVR 和 SAVR 治疗趋势，近50%重度主动脉瓣狭窄患者进行TAVR治疗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=389fe3975635)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1394665, encodeId=33351394665f6, content=<a href='/topic/show?id=d85b1e2171d' target=_blank style='color:#2F92EE;'>#TCT#</a>, objectTitle=关于预防宫颈癌，TCT检查的几点认知, objectType=article, longId=279686, objectId=7ff62e968679, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ff62e968679, replyNumber=0, likeNumber=64, createdTime=2021-11-10, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ff62e968679, moduleTitle=关于预防宫颈癌，TCT检查的几点认知, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7ff62e968679)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1394666, encodeId=0127139466655, content=<a href='/topic/show?id=d85b1e2171d' target=_blank style='color:#2F92EE;'>#TCT#</a>, objectTitle=揭秘妇科检查之HPV与TCT, objectType=article, longId=279163, objectId=ee462e9163a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee462e9163a4, replyNumber=0, likeNumber=0, createdTime=2021-11-10, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee462e9163a4, moduleTitle=揭秘妇科检查之HPV与TCT, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ee462e9163a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1394667, encodeId=b4e7139466e82, content=<a href='/topic/show?id=d85b1e2171d' target=_blank style='color:#2F92EE;'>#TCT#</a>, objectTitle=妇科检查之HPV、TCT, objectType=article, longId=277192, objectId=af1d2e7192a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af1d2e7192a5, replyNumber=0, likeNumber=84, createdTime=2021-11-10, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af1d2e7192a5, moduleTitle=妇科检查之HPV、TCT, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=af1d2e7192a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1394664, encodeId=6679139466479, content=<a href='/topic/show?id=d85b1e2171d' target=_blank style='color:#2F92EE;'>#TCT#</a>, objectTitle=TCT 2020｜VOYAGER PAD研究：药物涂层装置在外周动脉血运重建中长期安全性得到认可, objectType=article, longId=205018, objectId=a5962050186e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5962050186e, replyNumber=0, likeNumber=0, createdTime=2021-01-01, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5962050186e, moduleTitle=TCT 2020｜VOYAGER PAD研究：药物涂层装置在外周动脉血运重建中长期安全性得到认可, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a5962050186e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1394663, encodeId=d4f01394663c4, content=<a href='/topic/show?id=d85b1e2171d' target=_blank style='color:#2F92EE;'>#TCT#</a>, objectTitle=TCT 2020｜王盛教授点评：应用替西罗莫司药物的外膜递送系统为BTK的治疗提供新思路, objectType=article, longId=203002, objectId=53832030020b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53832030020b, replyNumber=0, likeNumber=71, createdTime=2020-11-08, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53832030020b, moduleTitle=TCT 2020｜王盛教授点评：应用替西罗莫司药物的外膜递送系统为BTK的治疗提供新思路, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=53832030020b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1394662, encodeId=c99e13946628b, content=<a href='/topic/show?id=d85b1e2171d' target=_blank style='color:#2F92EE;'>#TCT#</a>, objectTitle=TCT 2020丨ILLUMENATE 研究：低剂量紫杉醇药物涂层球囊在股腘动脉病变中的四年研究结果, objectType=article, longId=202992, objectId=9578202992c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9578202992c8, replyNumber=0, likeNumber=79, createdTime=2020-11-08, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9578202992c8, moduleTitle=TCT 2020丨ILLUMENATE 研究：低剂量紫杉醇药物涂层球囊在股腘动脉病变中的四年研究结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9578202992c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1394661, encodeId=61db13946618c, content=<a href='/topic/show?id=d85b1e2171d' target=_blank style='color:#2F92EE;'>#TCT#</a>, objectTitle=TCT 2020丨COMPARE CRUSH试验：PCI术前使用普拉格雷粉碎片剂无再灌注益处, objectType=article, longId=202678, objectId=89ff2026e882, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89ff2026e882, replyNumber=0, likeNumber=74, createdTime=2020-11-01, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89ff2026e882, moduleTitle=TCT 2020丨COMPARE CRUSH试验：PCI术前使用普拉格雷粉碎片剂无再灌注益处, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=89ff2026e882)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1394660, encodeId=b1151394660f5, content=<a href='/topic/show?id=d85b1e2171d' target=_blank style='color:#2F92EE;'>#TCT#</a>, objectTitle=TCT 2020丨PROSPECT Ⅱ/ABSORB研究：易损斑块的预防性PCI？, objectType=article, longId=202674, objectId=98692026e485, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98692026e485, replyNumber=0, likeNumber=60, createdTime=2020-11-01, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98692026e485, moduleTitle=TCT 2020丨PROSPECT Ⅱ/ABSORB研究：易损斑块的预防性PCI？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=98692026e485)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1394659, encodeId=d59413946597d, content=<a href='/topic/show?id=d85b1e2171d' target=_blank style='color:#2F92EE;'>#TCT#</a>, objectTitle=TCT 2020丨比伐芦定与肝素在患者水平的荟萃分析引发了一场争论, objectType=article, longId=202667, objectId=452d20266e29, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=452d20266e29, replyNumber=0, likeNumber=67, createdTime=2020-10-31, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=452d20266e29, moduleTitle=TCT 2020丨比伐芦定与肝素在患者水平的荟萃分析引发了一场争论, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=452d20266e29)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1394658, encodeId=551513946589a, content=<a href='/topic/show?id=d85b1e2171d' target=_blank style='color:#2F92EE;'>#TCT#</a>, objectTitle=TCT 2020丨TICO-STEMI研究：在STEMI患者中应用替格瑞洛单药治疗与替格瑞洛联合阿司匹林治疗的随机临床试验, objectType=article, longId=202468, objectId=9f3d20246844, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f3d20246844, replyNumber=0, likeNumber=68, createdTime=2020-10-26, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f3d20246844, moduleTitle=TCT 2020丨TICO-STEMI研究：在STEMI患者中应用替格瑞洛单药治疗与替格瑞洛联合阿司匹林治疗的随机临床试验, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9f3d20246844)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1394657, encodeId=bb87139465eed, content=<a href='/topic/show?id=d85b1e2171d' target=_blank style='color:#2F92EE;'>#TCT#</a>, objectTitle=TCT 2020丨DEFINE-PCI研究：PCI术后残余缺血患者的1年结局, objectType=article, longId=202467, objectId=92f220246ed9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92f220246ed9, replyNumber=0, likeNumber=64, createdTime=2020-10-26, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92f220246ed9, moduleTitle=TCT 2020丨DEFINE-PCI研究：PCI术后残余缺血患者的1年结局, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=92f220246ed9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1394656, encodeId=157d1394656b6, content=<a href='/topic/show?id=d85b1e2171d' target=_blank style='color:#2F92EE;'>#TCT#</a>, objectTitle=TCT 2020丨ULTIMATE研究：血管内超声 vs. 冠状动脉造影指导下植入药物洗脱支架术后3年随访结果, objectType=article, longId=202303, objectId=338c202303da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=338c202303da, replyNumber=0, likeNumber=79, createdTime=2020-10-21, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=338c202303da, moduleTitle=TCT 2020丨ULTIMATE研究：血管内超声 vs. 冠状动脉造影指导下植入药物洗脱支架术后3年随访结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=338c202303da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1394655, encodeId=45781394655e9, content=<a href='/topic/show?id=d85b1e2171d' target=_blank style='color:#2F92EE;'>#TCT#</a>, objectTitle=TCT 2019 | TWILIGHT研究重磅发布，高危PCI患者使用替格瑞洛单药治疗获益显著, objectType=article, longId=180192, objectId=981118019267, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=981118019267, replyNumber=0, likeNumber=72, createdTime=2019-09-29, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=981118019267, moduleTitle=TCT 2019 | TWILIGHT研究重磅发布，高危PCI患者使用替格瑞洛单药治疗获益显著, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=981118019267)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1394654, encodeId=1b7313946548c, content=<a href='/topic/show?id=d85b1e2171d' target=_blank style='color:#2F92EE;'>#TCT#</a>, objectTitle=强大解读！HPV和TCT的报告单怎么看？, objectType=article, longId=153375, objectId=a0311533e545, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0311533e545, replyNumber=0, likeNumber=73, createdTime=2018-11-14, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0311533e545, moduleTitle=强大解读！HPV和TCT的报告单怎么看？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a0311533e545)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1394653, encodeId=784e13946533b, content=<a href='/topic/show?id=d85b1e2171d' target=_blank style='color:#2F92EE;'>#TCT#</a>, objectTitle=TCT 2018丨LRP研究：NIRS成像对冠脉易损斑块的检测效果较, objectType=article, longId=149840, objectId=c89f149840c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c89f149840c0, replyNumber=0, likeNumber=76, createdTime=2018-09-29, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c89f149840c0, moduleTitle=TCT 2018丨LRP研究：NIRS成像对冠脉易损斑块的检测效果较, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c89f149840c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1394652, encodeId=cb4d139465213, content=<a href='/topic/show?id=d85b1e2171d' target=_blank style='color:#2F92EE;'>#TCT#</a>, objectTitle=TCT 2018丨局麻是手术中高危患者行TAVR的良好选择, objectType=article, longId=149837, objectId=0d5014983ec4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d5014983ec4, replyNumber=0, likeNumber=62, createdTime=2018-09-29, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d5014983ec4, moduleTitle=TCT 2018丨局麻是手术中高危患者行TAVR的良好选择, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0d5014983ec4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1394651, encodeId=9f74139465160, content=<a href='/topic/show?id=d85b1e2171d' target=_blank style='color:#2F92EE;'>#TCT#</a>, objectTitle=TCT 2018 重磅丨张俊杰教授：ULTIMATE研究表明，IVUS引导的药物支架置入改善所有患者的临床结局, objectType=article, longId=149835, objectId=76bd14983571, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76bd14983571, replyNumber=0, likeNumber=64, createdTime=2018-09-29, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76bd14983571, moduleTitle=TCT 2018 重磅丨张俊杰教授：ULTIMATE研究表明，IVUS引导的药物支架置入改善所有患者的临床结局, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=76bd14983571)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

TCT

2020-05-29

ms5187542471278033 (审核中...)

前往app查看评论内容

#TCT#

TCT 2022：新型Bashir导管或将成为治疗肺栓塞的利器

2022-09-19

ms5187542471278033 (审核中...)

前往app查看评论内容

#TCT#

TCT 2022：患者-人工瓣膜不匹配（PPM）与TAVR术后死亡率增加有关

2022-09-19

ms5187542471278033 (审核中...)

前往app查看评论内容

#TCT#

TCT 2022：TAVR 和 SAVR 治疗趋势，近50%重度主动脉瓣狭窄患者进行TAVR治疗

2022-09-19

ms5187542471278033 (审核中...)

前往app查看评论内容

#TCT#

关于预防宫颈癌，TCT检查的几点认知

2021-11-10

ms5187542471278033 (审核中...)

前往app查看评论内容

#TCT#

揭秘妇科检查之HPV与TCT

2021-11-10

ms5187542471278033 (审核中...)

前往app查看评论内容

#TCT#

妇科检查之HPV、TCT

2021-11-10

ms5187542471278033 (审核中...)

前往app查看评论内容

#TCT#

TCT 2020｜VOYAGER PAD研究：药物涂层装置在外周动脉血运重建中长期安全性得到认可

2021-01-01

ms5187542471278033 (审核中...)

前往app查看评论内容

#TCT#

TCT 2020｜王盛教授点评：应用替西罗莫司药物的外膜递送系统为BTK的治疗提供新思路

2020-11-08

ms5187542471278033 (审核中...)

前往app查看评论内容

#TCT#

TCT 2020丨ILLUMENATE 研究：低剂量紫杉醇药物涂层球囊在股腘动脉病变中的四年研究结果

2020-11-08

ms5187542471278033 (审核中...)

前往app查看评论内容

#TCT#

TCT 2020丨COMPARE CRUSH试验：PCI术前使用普拉格雷粉碎片剂无再灌注益处

2020-11-01

ms5187542471278033 (审核中...)

前往app查看评论内容

#TCT#

TCT 2020丨PROSPECT Ⅱ/ABSORB研究：易损斑块的预防性PCI？

2020-11-01

ms5187542471278033 (审核中...)

前往app查看评论内容

#TCT#

TCT 2020丨比伐芦定与肝素在患者水平的荟萃分析引发了一场争论

2020-10-31

ms5187542471278033 (审核中...)

前往app查看评论内容

#TCT#

TCT 2020丨TICO-STEMI研究：在STEMI患者中应用替格瑞洛单药治疗与替格瑞洛联合阿司匹林治疗的随机临床试验

2020-10-26

ms5187542471278033 (审核中...)

前往app查看评论内容

#TCT#

TCT 2020丨DEFINE-PCI研究：PCI术后残余缺血患者的1年结局

2020-10-26

ms5187542471278033 (审核中...)

前往app查看评论内容

#TCT#

TCT 2020丨ULTIMATE研究：血管内超声 vs. 冠状动脉造影指导下植入药物洗脱支架术后3年随访结果

2020-10-21

ms5187542471278033 (审核中...)

前往app查看评论内容

#TCT#

TCT 2019 | TWILIGHT研究重磅发布，高危PCI患者使用替格瑞洛单药治疗获益显著

2019-09-29

ms5187542471278033 (审核中...)

前往app查看评论内容

#TCT#

强大解读！HPV和TCT的报告单怎么看？

2018-11-14

ms5187542471278033 (审核中...)

前往app查看评论内容

#TCT#

TCT 2018丨LRP研究：NIRS成像对冠脉易损斑块的检测效果较

2018-09-29

ms5187542471278033 (审核中...)

前往app查看评论内容

#TCT#

TCT 2018丨局麻是手术中高危患者行TAVR的良好选择

2018-09-29

ms5187542471278033 (审核中...)

前往app查看评论内容

#TCT#

TCT 2018 重磅丨张俊杰教授：ULTIMATE研究表明，IVUS引导的药物支架置入改善所有患者的临床结局

2018-09-29

科室
- - 订阅+
  - 更多科室
工具
服务